help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brue, T.
Right arrow Articles by Jaquet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brue, T.
Right arrow Articles by Jaquet, P.

Journal of Clinical Endocrinology & Metabolism, Vol 75, 1338-1344, Copyright © 1992 by Endocrine Society

ARTICLES

Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions

T Brue, E Caruso, I Morange, T Hoffmann, M Evrin, G Gunz, M Benkirane and P Jaquet
Service d'Endocrinologie, Hopital Nord, Marseille, France.

The monoclonal antibodies (MAbs) obtained in mice immunized with human PRL coupled to an anti-PRL MAb were screened for their ability to distinguish the glycosylated (G-) and nonglycosylated (NG-) forms of PRL. The 431-29 MAb exhibited high affinity binding for NG-PRL but little or no cross-reactivity to G-PRL. Using this antibody in conjunction with other MAbs which equally recognized both forms, we developed 2 immunoradiometric assays which were used to determine the amount of G- and NG-PRL in plasma. In 85 normal subjects, NG-PRL baseline levels averaged 6.6 +/- 3 micrograms/L, and represented 76 +/- 8% of the total PRL immunoreactivity. In 74 pregnant women, this proportion was significantly higher during the last 2 trimesters (84 +/- 4% and 85 +/- 6%), as compared to the first trimester (76 +/- 7%). In 6 healthy volunteers studied over 24 h, 79% of the NG-PRL peaks detected using the cluster algorithm occurred concomitantly to a G-PRL peak. The mean NG-PRL/PRL ratio was significantly higher during NG-PRL pulses (81 +/- 9%) than during valleys (71 +/- 12%). Similarly, this ratio was significantly increased during TRH or metoclopramide stimulated PRL secretion (to 88 +/- 7% and 86 +/- 6%, respectively). We conclude that 1) NG-PRL is the predominant immunoassayable form of PRL in plasma; 2) both G- and NG-PRL are cosecreted but NG-PRL is the main PRL form released during spontaneous or pharmacologically induced PRL secretion.


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
S. E. Hankinson, W. C. Willett, D. S. Michaud, J. E. Manson, G. A. Colditz, C. Longcope, B. Rosner, and F. E. Speizer
Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women
J Natl Cancer Inst, April 7, 1999; 91(7): 629 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Campino, C. Torres, S. Ampuero, S. Diaz, G.B. Gonzalez, and M. Seron-Ferre
Bioactivity of prolactin isoforms: lactation and recovery of menses in nursing women
Hum. Reprod., April 1, 1999; 14(4): 898 - 905.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Bellone, P. Astarita, E. Artusio, S. Silvestri, K. Mareschi, A. Turletti, S. Buttiglieri, G. Emanuelli, and L. Matera
Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor-Stimulated In Vitro Erythropoiesis
Blood, July 1, 1997; 90(1): 21 - 27.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society